Scoop has an Ethical Paywall
AstraZeneca Welcomes Provisional Consent For COVID-19 Vaccine In New Zealand
AstraZeneca welcomes the announcement made by the New Zealand Government and regulatory authority Medsafe today that COVID-19 Vaccine AstraZeneca has been granted provisional consent for individuals 18 years and older.
New Zealand secured 7.6 million doses of AstraZeneca’s COVID-19 vaccine, enough for 3.8 million people, through an advance purchase agreement late last year.
Country President of AstraZeneca Australia and New Zealand, Liz Chatwin, said: “We are pleased to receive this consent from New Zealand’s regulatory body today.
“In less than 12 months, more than 750 million doses of the Oxford-AstraZeneca COVID-19 vaccine have been released for supply to more than 170 countries. Our vaccine continues to be an important tool in overcoming the COVID-19 global health emergency, underpinned by our commitment to provide broad and equitable access, at no profit during the pandemic.”
ABOUT
ASTRAZENECA
AstraZeneca (LSE/STO/NYSE: AZN) is a
global, science-led biopharmaceutical company that focuses
on the discovery, development and commercialisation of
prescription medicines, primarily for the treatment of
diseases in three therapy areas – Oncology;
Cardiovascular, Renal & Metabolism; and Respiratory
& Immunology. Based in Cambridge, UK, AstraZeneca
operates in over 100 countries and its innovative medicines
are used by millions of patients worldwide.
For more information, please visit www.astrazeneca.com and www.astrazeneca.com.au
Whanganui Regional Museum: Historic Wedding Dress Unveiled, A Piece Of Marton’s Heritage
Donovan Ryan: Local Runner Takes Out Frontrunner Christchurch Marathon
University of Auckland: Tributes Flow For Much Loved Pacific Leader Melegalenu’u Ah Sam
NZEI: Ministry Of Education Cuts Will Disproportionately Affect Pasifika
Day One Hapai te Haeata: Call To Action For Young Filmmakers Against The Backdrop Of Funding Cuts
Toyota New Zealand: Three Races For Top Three To Decide TR86 Title